Article PDF
Rights and permissions
About this article
Cite this article
Kaye, S. P glycoprotein (P-gp) and drug resistance – time for reappraisal?. Br J Cancer 67, 641–643 (1993). https://doi.org/10.1038/bjc.1993.119
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.119
This article is cited by
-
Relationship of the expression of MDR1 gene product in hepato cellular carcinoma to invasion and metastasis
Chinese Journal of Cancer Research (1998)
-
Classical multidrug resistance in acute myeloid leukaemia
Medical Oncology (1997)
-
Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833
Cancer Chemotherapy and Pharmacology (1995)
-
Die Hemmung des P-Glykoprotein-mediierten, transepithelialen Zytostatikatransportes durch R-Verapamil, Cyclosporin SDZ PSC-833 und Tamoxifen in einem Adenokarzinom-Monolayer-Modell
European Surgery (1995)
-
Relative cytotoxicities of Adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines
Urological Research (1995)